값202020212022202320242025TTM투자 활동으로 인한 현금———————재무활동으로 인한 현금———————잉여 현금 흐름———————
ProQR Therapeutics N.V. - Ordinary Shares
ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer.